Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > I know I know!
View:
Post by Lesalpes29 on Jul 13, 2023 7:29am

I know I know!

It's taking too long to get a start of ph3 on panc cancer in my book. 90 days here an other 180 days their! Can we go faster Matt for the suffering people? I know I know things take time but am I the only one thinking it could go faster? GL anyway,
Comment by Noteable on Jul 13, 2023 8:47am
Yes ..you are the only one . Get over it.
Comment by fox7mf on Jul 13, 2023 8:51am
Nope. It is taking long. Hopefully the wait ends in the next 45 days, and hopefully it ends in buyout not partnership. This is a massive deal & we have to expect a lot of foot dragging & DD on the part of BP. With Pela's seeming infallibility it's going to cost a lot. Immunomedics ended up being a purchase that perhaps might not work as well as everyone believed. I believe Oncy ...more  
Comment by Noteable on Jul 13, 2023 10:04am
Obtaining the right acquistion price. when negotiating with a plethora of interested companies who historically operated in a conservative pharmaceutical business model fashion and who must now transition into a a a world of biotech which is focused on the complex world of biological products versus the simple and absolute world of pharmaceuticals, takes time, talent and the right mind-set to get ...more  
Comment by Noteable on Jul 13, 2023 10:13am
Just one example of the kind of change that is happening is that pharmaceutical life-cycle management that was historically headed by a single marketing 'chief' is over.The future is decentralized management which is demonstrating to be more productive. And when finally decided upon, significant organizational change involves an element time.
Comment by Noteable on Jul 13, 2023 12:05pm
https://www.fiercebiotech.com/biotech/former-bms-rd-chief-vessey-be-flagships-chief-scientist-latest-big-pharma-czar-moving
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities